Fidelity Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Fidelity Investments's BSX.PRA Position: Q2 2023 in Review

Fidelity Investments sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 299,376 shares — an estimated $36.1M sold.

Fidelity Investments first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $59.1M in Q1 2022. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

• Fidelity Investments reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
• Fidelity Investments sold 299,376 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $36.1M.
• Fidelity Investments first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
• Fidelity Investments's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $59.1M in Q1 2022.
• 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.